Mechanistic studies of the apoptosis induced by the macrocyclic natural product tetrandrine in MGC 803 cells

[1]  Chuan-Chao Wang,et al.  Geridonin, a novel derivative of oridonin, inhibits proliferation of MGC 803 cells both in vitro and in vivo through elevating the intracellular ROS , 2017, The Journal of pharmacy and pharmacology.

[2]  Tao Zhang,et al.  Radiation chemical studies of Gly-Met-Gly in aqueous solution , 2016, Free radical research.

[3]  Xiao-Jing Shi,et al.  Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer Agents. , 2016, Anti-cancer agents in medicinal chemistry.

[4]  Yu Ke,et al.  Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathway , 2016, Oncotarget.

[5]  Feng Xie,et al.  Inhibiting ROS-STAT3-dependent autophagy enhanced capsaicin–induced apoptosis in human hepatocellular carcinoma cells , 2016, Free radical research.

[6]  Hua Jiang,et al.  Anti-cancer effects of curcumin on lung cancer through the inhibition of EZH2 and NOTCH1 , 2016, Oncotarget.

[7]  Wenhua Li,et al.  Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy , 2016, Oncotarget.

[8]  Yu Zhou,et al.  Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation , 2016, PloS one.

[9]  M. Chance,et al.  Apigenin blocks IKKα activation and suppresses prostate cancer progression , 2015, Oncotarget.

[10]  Chunrong Yu,et al.  Synergistic anti‐tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21 , 2015, British journal of pharmacology.

[11]  Wei Liu,et al.  Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells , 2015, Asian journal of andrology.

[12]  Zhijia Wang,et al.  Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents. , 2015, Journal of medicinal chemistry.

[13]  A. Harvey,et al.  The re-emergence of natural products for drug discovery in the genomics era , 2015, Nature Reviews Drug Discovery.

[14]  J. Vishwanatha,et al.  c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine. , 2014, Biochemical pharmacology.

[15]  M. Cooper,et al.  Natural product and natural product derived drugs in clinical trials. , 2014, Natural product reports.

[16]  L. Qi,et al.  Use of the UPOINT phenotype system in treating Chinese patients with chronic prostatitis/chronic pelvic pain syndrome: a prospective study , 2014, Asian journal of andrology.

[17]  M. Wink,et al.  Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[18]  W. Qiu,et al.  Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells , 2014, Cell Death and Disease.

[19]  Qingsong Li,et al.  Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17 , 2014, Tumor Biology.

[20]  H. Zhang,et al.  An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion , 2013, International journal of nanomedicine.

[21]  D. Pang,et al.  Fangchinoline Induces G1 Arrest in Breast Cancer Cells Through Cell‐Cycle Regulation , 2013, Phytotherapy research : PTR.

[22]  R. Qin,et al.  Tetrandrine Induces Mitochondria-Mediated Apoptosis in Human Gastric Cancer BGC-823 Cells , 2013, PloS one.

[23]  Chunrong Yu,et al.  Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling , 2013, British Journal of Cancer.

[24]  T. He,et al.  Tetrandrine Suppresses Cancer Angiogenesis and Metastasis in 4T1 Tumor Bearing Mice , 2013, Evidence-based complementary and alternative medicine : eCAM.

[25]  Stefan Wetzel,et al.  Charting, navigating, and populating natural product chemical space for drug discovery. , 2012, Journal of medicinal chemistry.

[26]  É. Marsault,et al.  Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery. , 2011, Journal of medicinal chemistry.

[27]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[28]  T. He,et al.  Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer , 2011, Molecular Pharmacology.

[29]  Y. Kodera,et al.  Paclitaxel chemotherapy for the treatment of gastric cancer , 2009, Gastric Cancer.

[30]  Baorui Liu,et al.  Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids. , 2008, Cancer letters.

[31]  Stephen P. Hale,et al.  The exploration of macrocycles for drug discovery — an underexploited structural class , 2008, Nature Reviews Drug Discovery.

[32]  Hong-yan Cheng,et al.  Effects of tetrandrine on apoptosis and radiosensitivity of nasopharyngeal carcinoma cell line CNE. , 2007, Acta biochimica et biophysica Sinica.

[33]  Gema Moreno-Bueno,et al.  Telling Cells How to Die: Docetaxel Therapy in Cancer Cell Lines , 2007, Cell cycle.

[34]  N. Sharpless,et al.  ROS as a tumour suppressor? , 2006, Nature Cell Biology.

[35]  H. Saya,et al.  Mitogenic signalling and the p16INK4a–Rb pathway cooperate to enforce irreversible cellular senescence , 2006, Nature Cell Biology.

[36]  M. Butler.  Natural products to drugs: natural product-derived compounds in clinical trials. , 2005, Natural product reports.

[37]  Chun-ching Lin,et al.  Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells. , 2003, Life sciences.

[38]  Yung-Hyun Choi,et al.  Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells. , 2002, International journal of oncology.

[39]  J. Zweier,et al.  Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts , 1997, Science.

[40]  M. Clarke,et al.  The Bcl-2 family of proteins: regulators of cell death and survival. , 1994, Trends in cell biology.

[41]  C. Rodrigues,et al.  Death receptors and mitochondria: two prime triggers of neural apoptosis and differentiation. , 2013, Biochimica et biophysica acta.

[42]  D. Levine,et al.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[43]  Lorenzo Galluzzi,et al.  Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.

[44]  Mark S Butler,et al.  Natural products to drugs: natural product derived compounds in clinical trials. , 2005, Natural product reports.

[45]  Ludger A. Wessjohann,et al.  What can a chemist learn from nature’s macrocycles? – A brief, conceptual view , 2005, Molecular Diversity.

[46]  L. Fu,et al.  The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. , 2002, European journal of cancer.

[47]  D. Chao,et al.  BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.